Oculis Operations Sàrl
Recorded under 2 name spellings.
Previously recorded as Oculis Operations GmbH (to 2024)
When these terms end
Fee deadlines
No maintenance fee falls due on this company's record before Nov 22, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,233,133 | Preparation of Solid Cyclodextrin Complexes for Ophthalmic Active Pharmaceutical Ingredient Delivery In force · Medium confidence | In force | Medium confidence | |
| US 12,521,448 | Preparation of Solid Cyclodextrin Complexes for Ophthalmic Active Pharmaceutical Ingredient Delivery In force · Medium confidence | In force | Medium confidence | |
| US 12,383,565 | Treatment of Diabetic Retinopathy with Ophthalmic Compositions In force · Low confidence | In force | Low confidence | |
| US 12,397,000 | Stabilized Ophthalmic Dexamethasone Compositions In force · High confidence | In force | High confidence | |
| US 12,397,001 | Treatment of Ocular Inflammation with Ophthalmic Compositions In force · High confidence | In force | High confidence | |
| US 12,397,002 | PH Stabilized Ophthalmic Dexamethasone Compositions In force · High confidence | In force | High confidence | |
| US 12,403,147 | Treatment of Ocular Inflammation Following Ocular Surgery In force · High confidence | In force | High confidence | |
| US 12,403,148 | PH Stabilized Ophthalmic Compositions In force · High confidence | In force | High confidence |
Sources and methods
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 abandoned · 2 no status recorded
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/313,674 | PH Stabilized Ophthalmic Compositions | Aug 28, 2025 | Pending |
| 19/244,594 | Synthesis of Small Molecule Agonists of Neuroptrophin | Jun 20, 2025 | Pending |
| 18/917,928 | Method of Treating Diabetic Macular Edema | Oct 16, 2024 | Pending |
| 18/792,377 | Aug 1, 2024 | No status recorded | |
| 18/383,999 | Ocular Inflammation Treatment with Stabilized Dexamethasone | Oct 26, 2023 | Abandoned |
| 18/383,987 | Oct 26, 2023 | No status recorded |